| Donors | Recipients | ||||
---|---|---|---|---|---|---|
N (m/f) | 20 (6/14) | 20 (14/6) | ||||
Age (a) | 46 (27-66) | 42 (6-77) | ||||
 | Baseline | 6 weeks after LDKT | 6 months after LDKT | Baseline | 6 weeks after LDKT | 6 months after LDKT |
eGFR (mL/min per 1.73 m2) | 84 (68-139)a*** | 58 (40-94)b | 57 (40-88)b | 8 (5-16)A | 61 (24-145)B | 63 (19-172)B |
Proteinuria (mg/L) | 47 (40-260) *** | 40 (40-92) * | 44 (40-105) * | 544 (42-1943) | 175 (37-762) | 73 (45-1238) |
UP/UC | 0.09 (0.04-0.84) *** | 0.10 (0.04-0.27) | 0.09 (0.04-0.17) | 0.78 (0.05-4.43)A | 0.13 (0.06-0.37)B | 0.10 (0.03-1.44)B |
CRP (mg/dL) | 0.17 (0.04-2.13) | 0.34 (0.03-1.21) | 0.28 (0.04-2.72) | 0.21 (0.02-1.45) | 0.26 (0.02-3.91) | 0.22 (0.02-2.57) |
Total cholesterol (mg/dL) | 182 (141-279) | 177 (142-289) | 193 (118-269) | 182 (126-353)A | 193 (90-291)AB | 191 (134-312)B |
LDL cholesterol (mg/dL) | 116 (67-214) | 115 (72-211) | 126 (68-188) | 120 (76-240) | 131 (72-222) | 126 (72-204) |
HDL cholesterol (mg/dL) | 58 (39-94) ** | 53 (36-90) | 56 (35-92) | 46 (29-71)A | 52 (36-119)B | 50 (30-78)B |
Trigylcerides (mg/dL) | 94 (46-298) *** | 124 (64-292) ** | 116 (72-397) * | 230 (81-671) | 207 (81-443) | 179 (81-545) |
ROH (μg/mL) | 0.61 (0.37-0.84)a*** | 0.81 (0.41-1.07)b | 0.67 (0.43-1.09)b | 1.46 (0.67-2.25)A | 0.88 (0.38-1.79)B | 1.01 (0.32-1.44)B |
RBP4 (μmol/L) | 1.76 (1.08-2.13)a*** | 2.11 (1.02-3.38)b | 2.55 (1.19-3.89)c | 6.57 (3.19-8.77)A | 2.80 (1.10-6.38)B | 3.06 (0.99-5.23)B |
TTR (μmol/L) | 2.58 (0.96-5.78) *** | 3.25 (0.47-5.06) | 3.08 (1.91-4.99) | 5.60 (2.06-8.37)A | 3.51 (1.58-8.24)B | 4.53 (1.05-6.38)B |
apoRBP4 (%) | 0.0 (0.0-8.2)a*** | 8.3 (0.6-13.1)b | 7.6 (0.3-9.6)b | 30.7 (1.2-47.6)A | 12.9 (0.8-23.4)B | 10.2 (0.6-31.0)B |